Purdue, Impax Patent Fight Comes To An End
A patent infringement suit filed over blockbuster painkiller OxyContin has been dismissed, after a court approved the settlement reached between OxyContin maker Purdue Pharma and generic pharmaceutical company Impax Laboratories....To view the full article, register now.
Already a subscriber? Click here to view full article